COVID-19

Brii Biosciences Launches Amubarvimab/Romlusevimab Combination in China for the Treatment of COVID-19

Brii Biosciences Launches Amubarvimab/Romlusevimab Combination in China for the Treatment of COVID-19

Shots: Brii Bio launched amubarvimab + romlusevimab in China as a long-acting COVI...

Pfizer Reports NDA Submission of Paxlovid to the US FDA for the Treatment of COVID-19

Pfizer Reports NDA Submission of Paxlovid to the US FDA for the Treatment of COVID-19

Shots: The NDA was submitted based on the P-II/III (EPIC-HR) & (EPIC-SR) trial...

Sanofi and GSK Report Results of COVID-19 Vaccine in the P-III (VAT08) Trial Against Omicron

Sanofi and GSK Report Results of COVID-19 Vaccine in the P-III (VAT08) Trial Against Omicron

Shots:  The P-III (VAT08) trial evaluated an adjuvanted bivalent D614 & B...

Image